Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal fusion in…
In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal fusion in…
Im 16. Jahr in Folge ehrt die Bayer Bitterfeld GmbH herausragende wissenschaftliche Leistungen am Institut für Pharmazie…
MagnetOs is the first open fibrillar collagen matrix bone graft substitute to receive clearance to market for interb…
Positively ground indexable inserts are ideal for machining special tasks and materials. They produce the best results w…
Third-quarter revenue amounts to CHF 571 million, an increase of 11% organic growth, bringing revenue in the first n…
Canada Silver Cobalt Works Inc. (TSXV: CCW) (OTC: CCWOF) (Frankfurt: 4T9B) (das „Unternehmen“ oder „Canada Silver Cobalt…
Direct MagnetOs sales grew to CHF 20.4 million in the first nine months of 2023, climbing from CHF 8.1 million in th…
Dr Adriana Locher is a brilliant surgeon who also shares her knowledge as a digital opinion leader. The Argentinian focu…
Freudenberg Sealing Technologies’ commitment to achieving net zero emissions by 2045, or sooner, is driving enormous cha…
Eckert & Ziegler (ISIN DE0005659700, TecDAX) today announced they have entered into a comprehensive collaboration agreem…